Health and Fitness Health and Fitness
Wed, August 11, 2010
Tue, August 10, 2010
[ Tue, Aug 10th 2010 ] - Market Wire
Johnson Retires from The First

Labopharm announces U.S. launch of OLEPTRO(TM) for treatment of major depressive disorder in adults


Published on 2010-08-10 06:10:23 - Market Wire
  Print publication without navigation


 ------------------------------------------------------------------------- WARNING: SUICIDALITY AND ANTIDEPRESSANT DRUGS See full prescribing information for complete boxed warning. Increased risk of suicidal thinking and behavior in children, adolescents and young adults taking antidepressants for major depressive disorder (MDD) and other psychiatric disorders. Oleptro(TM) is not approved for use in pediatric patients. ------------------------------------------------------------------------- 
 ----------------------------- (i) Bostwick, J.M., A Generalist's Guide to Treating Patients with Depression with an Emphasis on Using Side Effects to Tailor Antidepressant Therapy. Mayo Clin Proc. 2010;85(6):538-550 (ii) Lin E.H. et al. Medcare.1995;33:67-74